Paper78051
Immunoproliferation and cancer: a common macrophage-derived promoter substance.
Salmon SE and 1 other. Lancet, 1978. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Immunoproliferation and cancer: a common macrophage-derived promoter substance. Papers, record 78051. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/78051
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody-Producing Cells | Major topic |
| B-Lymphocytes | Major topic |
| Growth Substances | Major topic |
| Macrophages | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Cell Division | |
| Clone Cells | |
| Epidermal Growth Factor | |
| Humans | |
| In Vitro Techniques | |
| Mice | |
| Models, Biological | |
| Neoplasm Metastasis |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29375123 | The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? | Cell Mol Immunol | 2018 | https://conductscience.org/library/papers/29375123 | PubMed |
| 7426298 | Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7426298 | PubMed |
| 7295507 | Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7295507 | PubMed |
| 7250325 | Changes in immune reactivity during growth of an adenovirus 12-induced transplantable tumour in CBA mice. | Experientia | 1981 | https://conductscience.org/library/papers/7250325 | PubMed |
| 7238796 | A simple procedure for removal of intra- and extra-tumoral macrophages from primary tumor cultures. | Experientia | 1981 | https://conductscience.org/library/papers/7238796 | PubMed |
| 6789682 | I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages. | Am J Pathol | 1981 | https://conductscience.org/library/papers/6789682 | PubMed |
| 6764378 | Macrophages and neoplasms: new insights and their implication in tumor immunobiology. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6764378 | PubMed |
| 6699074 | The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas. | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6699074 | PubMed |
| 6500600 | Enhancement of rat ACT-1 tumor clonogenicity by xenogeneic mouse macrophages. | In Vitro | 1984 | https://conductscience.org/library/papers/6500600 | PubMed |
| 6332671 | Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6332671 | PubMed |
| 3664532 | Infiltration of primary and metastatic melanomas with macrophages of the 25F9-positive phenotype. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3664532 | PubMed |
| 3464353 | Immunoregulating activity of tumor-associated macrophages. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3464353 | PubMed |
| 3057504 | Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3057504 | PubMed |
| 1280562 | Prediction of response to drug therapy of cancer. A review of in vitro assays. | Drugs | 1992 | https://conductscience.org/library/papers/1280562 | PubMed |
| 455581 | Vindesine. A clinical trial with special reference to neurological side effects. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/455581 | PubMed |
| 314909 | Peritoneal macrophages from adjuvant arthritic rats enhance tumour cell growth in vitro. | Experientia | 1979 | https://conductscience.org/library/papers/314909 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/78051
GET https://conductscience.org/api/papers/v1/78051/authors